Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.
about
Identification of unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitisLack of association between measles virus vaccine and autism with enteropathy: a case-control studyHyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trialImpaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbancesThe role of immune dysfunction in the pathophysiology of autismStem cell therapy for autismThe Impact of Neuroimmune Alterations in Autism Spectrum DisorderConsensus paper: pathological role of the cerebellum in autismCytokine dysregulation in autism spectrum disorders (ASD): possible role of the environmentHyperbaric oxygen treatment in autism spectrum disordersMicrobe HuntingCan probiotics benefit children with autism spectrum disorders?Duodenal lymphocytosis with no or minimal enteropathy: much ado about nothing?Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feelingAutistic enterocolitis; is it a histopathological entity?The gluten-free, casein-free diet in autism: an overview with clinical implicationsIn search of cellular immunophenotypes in the blood of children with autismAutistic enterocolitis: is it a histopathological entity??replyUnique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.Altered T cell responses in children with autism.Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder.Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomesImmune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersThe potential role of probiotics in the management of childhood autism spectrum disorders.The Study to Explore Early Development (SEED): a multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network.Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old.Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in AutismDecreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction.Histopathological alterations in irritable bowel syndrome.Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?Altered gene expression and function of peripheral blood natural killer cells in children with autism.Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.Immune dysfunction in autism: a pathway to treatment.The neurobiology of lipid metabolism in autism spectrum disorders.Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection?Nutritional management of (some) autism: a case for gluten- and casein-free diets?
P2860
Q21133642-D3591631-E535-4C71-AAE8-0AB2B0CBBF9AQ21144239-93EC73A3-FBF7-4563-9E74-D0FC1CCD01FAQ21260340-C27E1AC6-128F-4374-98B0-860244678DCAQ21560928-B0EC0DFD-BAD8-424A-901F-99505EC5954FQ22252518-EF50CB5C-41BC-4083-901C-1ACA22D8D799Q24676771-13B13BD4-CF98-4032-99E4-4C9FD660832CQ26781540-14D814A0-72CF-48EE-BF80-1365C8BF4460Q26830626-A6A2E71D-51CE-42B1-A6E1-5EBC057F4A00Q27011394-B8CCC201-5FE3-4A71-A3C2-D4473547802CQ27499262-836235E6-7F8D-40C9-B9D9-B835F4957071Q27890382-91528F84-6A02-4416-BB79-EB7B28EDA84DQ28076833-C5F771E1-C280-4C38-8FDB-D693B87FFAF7Q28081621-05C4CC70-E31B-499F-A22A-CA7308A8056FQ28244133-F3106174-C999-4E7F-9C07-DB782CE34111Q28285313-4CAC35F2-DDDC-4761-8BD7-ED966CACF528Q28301783-917C307F-0270-4FA5-BC27-152E26E477F4Q28740461-BEEEF56F-5D0E-4E90-B07B-78AFACCD66B7Q29038775-AFD48875-9704-4D20-BBD0-BCBCE08152A5Q30534798-C18DD0ED-072F-47DF-9F11-66F995B4495EQ34348399-59A51195-430A-4A0F-B5E8-8086DB918E23Q34577189-6ED731E5-C154-4FED-944C-D93C4D57049EQ34679849-CF24E1EA-FBA0-4D2C-A795-5A8FCD478FD9Q34818778-1EC7A9E5-1210-4EE9-8A74-59BD55CF180AQ35144045-43E97572-5DCF-4806-A625-83D14921895AQ35246024-EFBCABC7-D332-4F43-A23A-86BD8D5C65A4Q35494817-5A7E1AD2-B1BB-4CF1-8374-6B1D8EAF0C58Q35683981-DAD99F1F-F89F-4A98-82DE-2BA4613CF25AQ35990473-D68A7540-CF72-4DFD-9023-62E233A76A25Q36168459-F5FA9FAE-6A87-4DD2-96A7-56D1F7BB9E21Q36205011-1B333824-FCB0-4D80-B4B3-A70B27A5DE14Q36609410-8A9F080F-6A3B-45C2-B877-0F4D8AD932A7Q36766427-C99A14B3-CB19-4EB8-BE1B-C244923F8AB3Q37085371-22B93D2D-9FA0-4B9A-AC35-9E3EC24508C4Q37106022-FE0B81E9-6FF3-4A91-A1E5-FBBE77248673Q37217132-7EBDE07C-D859-41EC-93CD-848B36468E6FQ37280911-49041960-559E-431B-9D51-EDCD3B67EEDAQ37774097-A8E5D2E4-B3AA-4816-8ED6-0BDB477595CEQ37846445-59B458FB-8510-4931-AE0C-7185E0DDEB8AQ37903849-4157B92B-CEC9-4B90-8458-8795DE59EB43Q38259734-ABA53342-44FC-425A-B9E5-76B8660387E8
P2860
Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@ast
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@en
type
label
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@ast
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@en
prefLabel
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@ast
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@en
P2093
P1476
Spontaneous mucosal lymphocyte ...... ter regulatory interleukin-10.
@en
P2093
Andrew Anthony
Andrew J Wakefield
Franco Torrente
Paul Ashwood
P2888
P304
P356
10.1007/S10875-004-6241-6
P577
2004-11-01T00:00:00Z
P5875
P6179
1039109088